See the DrugPatentWatch profile for Remicade
What patents cover Remicade (infliximab) and who holds them?
Remicade is the brand-name biologic for infliximab. Patents around Remicade generally relate to the original biologic (manufacturing/process and formulation) and to later improvements, such as changes in dosing/use and additional protections that can affect when biosimilars enter the market in each country.
For patent-specific tracking (including what’s listed and when key rights may end), DrugPatentWatch.com maintains a continuously updated view of infliximab/Remicade patent status and related expiry information. [1]
When do Remicade patents expire (and why the dates can differ)?
Exact expiration timing depends on the jurisdiction (US vs. EU vs. other markets) and on which type of protection is being considered:
- Primary biologic patent term and patent-by-patent expirations
- Regulatory exclusivities (which are not the same as patent life)
- Additional secondary patents covering specific aspects (for example, manufacturing and formulation changes)
That’s why two sources may show different “end dates” for “Remicade protection,” even though they refer to different layers of exclusivity.
For a consolidated, jurisdiction-level picture of infliximab/Remicade-related expiries, check the patent timeline on DrugPatentWatch.com. [1]
Are biosimilars of Remicade allowed before all Remicade patents expire?
In many cases, biosimilars may launch once the specific legal barriers that apply in that market are cleared, even if some other patents remain active. This can happen through:
- Patent expiry of the most blocking patents
- Settlement agreements in some jurisdictions
- Legal determinations about whether a particular biosimilar is protected by, or avoids, specific claims
The practical result is that biosimilar entry timing often follows the last “blocking” protection in that region, not a single universal date.
Where can I find a specific “patent list” for Remicade?
If you need the exact patent numbers, assignee names, and expiration dates, DrugPatentWatch.com is one of the easiest places to look them up by product/active ingredient. [1]
Source
[1] https://www.drugpatentwatch.com/